Evidence map›Paper›PMID 42089481›Full record

ArticleJournal of the American Chemical Society2026

Interface Architecture of a VHL-PROTAC Complex with and without Cullin-2.

Evan N Whitford, Joshua D Gilbert, Marius M Kostelic, Aaron C Ehlinger, Tiffany A Thibaudeau, Shaun M McLoughlin, Vicki H Wysocki

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evan N WhitfordSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0009-0005-1120-0889
Joshua D GilbertNative MS Guided Structural Biology Center, The Ohio State University, Columbus, Ohio 43210, United States.
Marius M KostelicNative MS Guided Structural Biology Center, The Ohio State University, Columbus, Ohio 43210, United States.
Aaron C EhlingerTarget Enabling Technologies, AbbVie, 1 N. Waukegan Rd, North Chicago, Illinois 60064, United States.
Tiffany A ThibaudeauTarget Enabling Technologies, AbbVie, 1 N. Waukegan Rd, North Chicago, Illinois 60064, United States.
Shaun M McLoughlinTechnology and Therapeutic Platforms, AbbVie, 1 N. Waukegan Rd, North Chicago, Illinois 60064, United States.
Vicki H WysockiSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0003-0495-2538

Funding

Native Mass Spectrometry Guided Structural Biology CenterRM1GM149374 · NIGMS · OHIO STATE UNIVERSITY · PI Vicki H. Wysocki · 2023 to 2026
$5.0M
Molecular biophysics predoctoral training at the Ohio State UniversityT32GM144293 · NIGMS · OHIO STATE UNIVERSITY · PI CHARLES E BELL, Ralf A Bundschuh · 2022 to 2026
$1.1M
NIGMS NIH HHS RM1 GM149374NIGMS NIH HHS T32 GM144293
6 · The paper itself

Abstract

Proteolysis Targeting Chimeras (PROTACs) are bispecific molecules that link a target protein to an E3 ligase, leading to ubiquitination and subsequent degradation. Their efficacy depends on their ability to form ternary complexes for target ubiquitination, which is influenced by protein-protein interactions. Native mass spectrometry combined with surface-induced dissociation (SID) is a sensitive technique for rapidly assessing protein structures, including stoichiometry and interfacial strengths. Native mass spectrometry can also capture a variety of conformational states in the gas phase, reflecting the intrinsic flexibility of many protein assemblies. This ability to resolve structural heterogeneity and transient subpopulations provides complementary insights not as readily accessible through crystallography, cryo-EM, or other ensemble-averaging assays. By coupling native mass spectrometry with surface-induced dissociation, topological features, specifically relative interfacial strengths and subcomplex arrangements, were probed

Indexed as

Cullin ProteinsVon Hippel-Lindau Tumor Suppressor ProteinHumansModels, MolecularProteolysis Targeting ChimeraCUL2 protein, humanCullin ProteinsProteolysis Targeting ChimeraVHL protein, humanVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID42089481
PMCPMC13195672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.